XML 34 R32.htm IDEA: XBRL DOCUMENT v2.4.0.6
Acquisitions (Details 1) (USD $)
3 Months Ended 9 Months Ended 3 Months Ended 3 Months Ended 3 Months Ended 3 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Sep. 30, 2011
Mar. 31, 2011
Sep. 30, 2012
R&D- and commercialization-based milestones [Member]
Sep. 30, 2012
revenue-based payments [Member]
Monte Carlo [Member]
Sep. 30, 2012
revenue-based payments [Member]
Discounted cash flow [Member]
Jun. 30, 2012
twenty twelve acquisitions [Domain]
Jun. 08, 2012
twenty twelve acquisitions [Domain]
Jun. 30, 2012
twenty twelve acquisitions [Domain]
Technology-related [Member]
Jun. 30, 2012
twenty twelve acquisitions [Domain]
Customer Contracts [Member]
Jan. 04, 2011
Sadra Medical Inc [Member]
Jan. 05, 2011
Intelect Medical Inc [Member]
Sep. 30, 2012
2011 Acquisitions [Member]
Mar. 31, 2011
2011 Acquisitions [Member]
Jan. 05, 2011
2011 Acquisitions [Member]
Sep. 30, 2012
Maximum [Member]
R&D- and commercialization-based milestones [Member]
Sep. 30, 2012
Maximum [Member]
revenue-based payments [Member]
Monte Carlo [Member]
Sep. 30, 2012
Maximum [Member]
revenue-based payments [Member]
Discounted cash flow [Member]
Sep. 30, 2012
Minimum [Member]
R&D- and commercialization-based milestones [Member]
Sep. 30, 2012
Minimum [Member]
revenue-based payments [Member]
Monte Carlo [Member]
Sep. 30, 2012
Minimum [Member]
revenue-based payments [Member]
Discounted cash flow [Member]
Jun. 30, 2012
Purchased research and development [Member]
twenty twelve acquisitions [Domain]
Sep. 30, 2012
Low end of range [Member]
Technology-related [Member]
Sep. 30, 2012
Low end of range [Member]
Purchased research and development [Member]
Sep. 30, 2012
High end of range [Member]
Technology-related [Member]
Sep. 30, 2012
High end of range [Member]
Purchased research and development [Member]
Jun. 30, 2012
Japan [Member]
twenty twelve acquisitions [Domain]
Sep. 30, 2012
Japan [Member]
2011 Acquisitions [Member]
Jun. 30, 2012
Segment, Geographical, Groups of Countries, Group Two [Member]
twenty twelve acquisitions [Domain]
Sep. 30, 2012
Segment, Geographical, Groups of Countries, Group Two [Member]
2011 Acquisitions [Member]
Jun. 30, 2012
Segment, Geographical, Groups of Countries, Group One [Member]
twenty twelve acquisitions [Domain]
Sep. 30, 2012
Segment, Geographical, Groups of Countries, Group One [Member]
2011 Acquisitions [Member]
Jun. 30, 2012
United States [Member]
twenty twelve acquisitions [Domain]
Sep. 30, 2012
United States [Member]
2011 Acquisitions [Member]
Business Acquisition [Line Items]                                                                        
InProcessResearchandDevelopmentReclassified $ 47,000,000                                                                      
Benefit related to change in fair value of contingent liability 20,000,000   9,000,000                                                                  
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability   6,000,000   18,000,000                                                                
Payments to Acquire Businesses, Net of Cash Acquired                   134,000,000     193,000,000 60,000,000 370,000,000                                          
Pre-acquisition equity interest                         14.00% 15.00%                                            
Business Acquisition, Percentage of Voting Interests Acquired                         86.00% 85.00%                                            
Business Acquisition, Contingent Consideration, at Fair Value         287,000,000 305,000,000 114,000,000 185,000,000   259,000,000         (287,000,000)                                          
Estimated fair value of prior equity ownership interest in Sadra and Intelect                   79,000,000         55,000,000                                          
Business Acquisition, Purchase Price Allocation, Notes Payable and Long-term Debt                   9,000,000                                                    
Business Acquisition, Cost of Acquired Entity, Purchase Price                   481,000,000         712,000,000                                          
Gain On Transactions                 39,000,000             38,000,000                                        
Risk-adjusted discount rate for contingent consideration                                   2.40%   18.00% 0.00%   12.00%                          
contingent consideration liability, probability of payment             100.00%                     100.00%   100.00% 13.00%   65.00%                          
contingent consideration liability, projected year of payment                                   2017 2018 2018 2012 2013 2012                          
Allocation of purchase price to various intangible asset categories                                                                        
Amortizable intangible assets                   42,000,000 40,000,000 2,000,000     97,000,000                                          
Indefinite-lived intangible assets                   48,000,000         470,000,000                 48,000,000                        
Business Acquisition, Purchse Price Allocation, Net Intangible Assets                 90,000,000           567,000,000                                          
Weighted Average Amortization Period (in years)                     11 years 5 years     7 years 4 months 24 days                                          
Range Of Risk Adjusted Discount Rates Used In Purchase Price Allocation                     14.00% 14.00%                       14.00% 22.60% 23.60% 25.00% 30.00%                
Business Acquisition, Purchase Price Allocation, Other Noncurrent Assets                   3,000,000                                                    
Allocation of goodwill acquired to reportable segments                                                                        
Goodwill                 314,000,000 314,000,000         266,000,000                           6,000,000 1,000,000 27,000,000 5,000,000 97,000,000 99,000,000 184,000,000 161,000,000
Estimated Total Cost To Complete In Process Research And Development Programs Acquired, low end of range                             250,000,000                                          
Estimated Total Cost To Complete In Process Research And Development Programs Acquired, high end of range                             300,000,000                                          
Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value                                 55,000,000                                      
Contingent payment related to business combination 0   4,000,000 0                                                                
Deferred income taxes                   $ 74,000,000         $ (121,000,000)